| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/01/2002 | WO2002059135A1 Compositions containing a ruthenium(iii) complex and a heterocycle |
| 08/01/2002 | WO2002059065A2 Oligo or polyalkylene glycol-coupled thrombin inhibitors |
| 08/01/2002 | WO2002058790A1 Fluid retention assembly for an iontophoretic delivery |
| 08/01/2002 | WO2002058750A2 A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same |
| 08/01/2002 | WO2002058749A2 Carrier with solid fibrinogen and solid thrombin |
| 08/01/2002 | WO2002058739A2 Orally ingestible baked radiopaque product for testing for dysphagia |
| 08/01/2002 | WO2002058737A2 Multivalent meningococcal polysaccharide-protein conjugate vaccine |
| 08/01/2002 | WO2002058736A2 Use of 9-substituted purine analogues and other molecules to stimulate neurogenesis |
| 08/01/2002 | WO2002058735A1 Method of preparing biological materials and preparation produced using same |
| 08/01/2002 | WO2002058733A2 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/01/2002 | WO2002058732A2 Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/01/2002 | WO2002058718A2 Use of compositions containing pdgf-bb for promoting angiogenesis |
| 08/01/2002 | WO2002058708A1 Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof |
| 08/01/2002 | WO2002058705A2 Degradation-resistant glucocorticosteroid formulations |
| 08/01/2002 | WO2002058701A1 Pharmaceutical dosage forms of epothilones for oral administration |
| 08/01/2002 | WO2002058700A1 Methods of administering epothilone analogs for the treatment of cancer |
| 08/01/2002 | WO2002058699A1 Pharmaceutical forms of epothilones for oral administration |
| 08/01/2002 | WO2002058694A2 Method of treating hematologic tumors and cancers using beta lapachone |
| 08/01/2002 | WO2002058689A1 Pharmaceutical compositions of fenretinide having increased bioavailability and methods of using the same |
| 08/01/2002 | WO2002058688A1 Use of neurotoxic substances in producing a medicament for treating joint pains |
| 08/01/2002 | WO2002058677A1 New film coating |
| 08/01/2002 | WO2002058676A1 Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profiles |
| 08/01/2002 | WO2002058671A1 Burst free pharmaceutical microparticules |
| 08/01/2002 | WO2002058670A1 Local anesthetic, and method of use |
| 08/01/2002 | WO2002058668A2 Artificial tear composition adapted to be used with contact lenses |
| 08/01/2002 | WO2002058666A2 Process for preparing non-hygroscopic sodium valproate composition |
| 08/01/2002 | WO2002058624A2 In situ generation allicin for the treatment of cancer and infectious diseases |
| 08/01/2002 | WO2002058622A2 Sn-38 lipid complexes and methods of use |
| 08/01/2002 | WO2002058608A1 Loratadine transdermal device and methods |
| 08/01/2002 | WO2002058586A2 Systemic formulations containing beta-carotene and derivatives thereof |
| 08/01/2002 | WO2002039992A3 Adducts of quinolonic agents with natural polysaccharide polymers |
| 08/01/2002 | WO2002038646A3 Novel polyesters, method for producing the same and depot medicaments produced from these polyesters |
| 08/01/2002 | WO2002036104A3 Inhalative solution formulation containing a tiotropium salt |
| 08/01/2002 | WO2002032410A3 Pharmaceutical composition comprising resveratrol for treating inflammatory respiratory disorders |
| 08/01/2002 | WO2002032233A3 Treatment and prophylaxis of diseases and infections of pigs and poultry with aivlosin |
| 08/01/2002 | WO2002019986A9 Inducing cellular immune responses to hepatitis b virus using peptide and nucleic acid compositions |
| 08/01/2002 | WO2002015876A3 Amorphous carrier materials for drug delivery |
| 08/01/2002 | WO2002009649A8 Cell internalized peptide-drug conjugates |
| 08/01/2002 | WO2002007783A3 Radiolabeled immunotoxins |
| 08/01/2002 | WO2002002505A3 Compounds to treat alzheimer's disease |
| 08/01/2002 | WO2001097862A3 Stabiliser for radiopharmaceuticals |
| 08/01/2002 | WO2001085148A3 Packaging regimen of pseudoephedrine hydrochloride and fexofenadine hydrocloride |
| 08/01/2002 | WO2001085106A3 Cosmetic agents containing 2-furanone derivatives |
| 08/01/2002 | WO2001083527A3 Glucagon antagonists |
| 08/01/2002 | WO2001082914A3 Topical anesthetic/opioid formulations and uses thereof |
| 08/01/2002 | WO2001075110A3 Mucin-1 specific binding members and methods of use thereof |
| 08/01/2002 | WO2001041800A9 Compositions and methods for stabilizing biological molecules upon lyophilization |
| 08/01/2002 | WO2001028494A9 Nordihydroguaiaretic derivatives for use in treatment of tumors |
| 08/01/2002 | US20020103343 Antigen-based heteropolymers and method for treating autoimmune diseases using the same |
| 08/01/2002 | US20020103285 Film coatings and film coating compositions based on polyvinyl alcohol |
| 08/01/2002 | US20020103261 Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals |
| 08/01/2002 | US20020103260 Combinations of formoterol and fluticasone proppionate for asthma |
| 08/01/2002 | US20020103259 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 08/01/2002 | US20020103254 Paclitaxel formulation |
| 08/01/2002 | US20020103232 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 08/01/2002 | US20020103225 Comprises solid amorphous dispersion of compounds such as (2R,4S)4-((3,5-dichloro-benzyl)-methoxycarbonyl-amino)-6,7-dimethoxy-2 -methyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester for elevating plasma lipid levels |
| 08/01/2002 | US20020103196 Stabilizing pharmaceutical composition by contacting with polymeric material containing an antioxidant; eye drops |
| 08/01/2002 | US20020103165 Engineered spray-dried lipid-based microparticles for cellular targeting |
| 08/01/2002 | US20020103161 Novel heterocycles |
| 08/01/2002 | US20020103160 Self-cross-linking alkyl cellulose derivative, production process therefor, and use thereof |
| 08/01/2002 | US20020103158 Dinucleoside polyphosphates which facilitate secretory mechanisms, i.e. increasing the hydration of mucus secretions, stimulating the production of mucins and increasing ciliary beat frequency to facilitate clearance |
| 08/01/2002 | US20020103157 Stimulation of tear secretion by administering uridine 5'-triphosphate dinucleotides, cytidine 5'-triphosphate, adenosine 5'-triphosphate or their useful analogs; enhances mucociliary clearance of nasolacrimal duct |
| 08/01/2002 | US20020103142 Protective, interactive, non-condensing compounds used to prolong localized bioavailability and enhancing expression of a nucleic acid; anticancer agents |
| 08/01/2002 | US20020103133 Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use |
| 08/01/2002 | US20020103113 Oligopeptide lyophilisate, their preparation and use |
| 08/01/2002 | US20020102733 Drug delivery system; obtain receptive binding particles, incubate with surface and hydrophilic polymer, incubate with release agent, monitor distribution through biological systems |
| 08/01/2002 | US20020102729 Formulations for electroporation |
| 08/01/2002 | US20020102666 PSCA: prostate stem cell antigen and uses thereof |
| 08/01/2002 | US20020102657 Binding protein for use as therapeutic tool in the prevention of Infections disease |
| 08/01/2002 | US20020102656 Modulating the immune response |
| 08/01/2002 | US20020102544 Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators |
| 08/01/2002 | US20020102317 For accelerating and amplifying the synthesis of thermal shock proteins of cells of living beings |
| 08/01/2002 | US20020102315 For therapy of diabetes to be administered perorally in form of tea, a tincture and a pill |
| 08/01/2002 | US20020102311 Time-release agents; drug delivery |
| 08/01/2002 | US20020102302 Stabilized sustained release tramadol formulations |
| 08/01/2002 | US20020102298 Temperature-sensitive liposomal formulation |
| 08/01/2002 | US20020102297 Macromolecule-lipid complexes and methods for making and using |
| 08/01/2002 | US20020102295 Compositions for application to the skin or hair |
| 08/01/2002 | US20020102288 Flexible applicator for applying oil-in-water emulsion with improved stability |
| 08/01/2002 | US20020102286 For use in air fresheners, laundry detergents, fabric softeners, deodorants, lotions |
| 08/01/2002 | US20020102281 Water-soluble concentrate obtained from liquid lipophilic materials of vegetables orgin and at least two ecologically optimized surfactants |
| 08/01/2002 | US20020102280 Solvent systems for pharmaceutical agents |
| 08/01/2002 | US20020102272 Composition for delivery of hematopoietic growth factor |
| 08/01/2002 | US20020102266 Stable vaccine compositions for parenteral administration, a method for their use, and a process for their preparation |
| 08/01/2002 | US20020102265 For diagnosis and imaging of cancer and tumor tissues |
| 08/01/2002 | US20020102264 Uses of monoclonal antibody 8H9 |
| 08/01/2002 | US20020102254 For diagnostic and therapeutic uses in cancer |
| 08/01/2002 | US20020102218 Stable, aerosolizable suspensions of proteins in ethanol |
| 08/01/2002 | US20020102217 For use in ultrasound imaging, contrast agents |
| 08/01/2002 | US20020102215 Diagnostic/therapeutic agents |
| 08/01/2002 | US20020100185 Drying method for selectively removing volatile components from wet coatings |
| 08/01/2002 | DE10104494A1 Verfahren zur Herstellung von Trockenpulvern eines oder mehrerer Carotinoide A process for preparing dry powders of one or more carotenoids |
| 08/01/2002 | DE10102878A1 Oligo- oder Polyalkylengekoppelte Thrombininhibitoren Oligo- or Polyalkylengekoppelte thrombin inhibitors |
| 08/01/2002 | DE10102009A1 Tensidgemisch Surfactant mixture |
| 08/01/2002 | DE10101307A1 Fumarsäurederivate als NF-kappaB-Inhibitor Fumaric acid derivatives as NF-kappaB inhibitor |
| 08/01/2002 | CA2563051A1 Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/01/2002 | CA2436076A1 Use of compositions containing pdgf-bb for promoting angiogenesis |
| 08/01/2002 | CA2435949A1 Biological organism for preparing pharmaceutical compositions for treating mammals |
| 08/01/2002 | CA2435888A1 Method of preparing biological materials and preparation produced using same |
| 08/01/2002 | CA2435418A1 Use of neurotoxic substances in producing a medicament for treating joint pains |